Christopher Sampson

Chris’s primary research interest is economic evaluation in health care, including the development of new methods for cost-effectiveness analysis and the valuation of health. He has worked on trial- and model-based economic evaluations in a variety of clinical fields. Chris is also dedicated to building new platforms for collaboration in the discipline of health economics.

Since 2010, Chris has worked alongside randomised trials and other clinical studies in a diverse range of fields including depression, orthotics, ADHD and stroke. His main expertise is in the collection and analysis of patient-reported outcomes and resource-use. For his PhD research, Chris evaluated risk-based screening in the context of the NHS Diabetic Eye Screening Programme. This study incorporated trial data collection, the development of a decision-analytic model, and the design of a framework for individualised cost-effectiveness analysis.

Chris holds several roles that enable him to contribute to the health economics community more widely. He runs The Academic Health Economists’ Blog, is the webmaster for the UK Health Economists’ Study Group, and is on the editorial board of PharmacoEconomics – Open.

Chris joined the Office of Health Economics in October 2017. Prior to this he worked as a health economist for the University of Nottingham. He has a BA in Economics and an MSc in Economics & Health Economics from the University of Sheffield.